메뉴 건너뛰기
The Lancet Oncology
Volumn 14, Issue 2, 2013, Pages 105-107
Renal-cell carcinoma: A step closer to a new classification
Author keywords

[No Author keywords available]
Indexed keywords

BAP1 GENE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CHROMOSOME 3P; EXOME; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; LETTER; OVERALL SURVIVAL; PBRM1 GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;
EID: 84873090037     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70599-5     Document Type: Letter
Times cited : (6)
References (9)
  • 1
    • 65949089138 scopus 로고    scopus 로고
    • Hereditary kidney cancer: unique opportunity for disease-based therapy
    • Linehan WM, Pinto PA, Bratslavsky G, et al. Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 2009, 115(10 suppl):2252-2261.
    • (2009) Cancer , vol.115 , Issue.10 SUPPL. , pp. 2252-2261
    • Linehan, W.M.1    Pinto, P.A.2    Bratslavsky, G.3
  • 2
    • 60349101704 scopus 로고    scopus 로고
    • VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy
    • Cowey CL, Rathmell WK VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy. Curr Oncol Rep 2009, 11:94-101.
    • (2009) Curr Oncol Rep , vol.11 , pp. 94-101
    • Cowey, C.L.1    Rathmell, W.K.2
  • 3
    • 48649098245 scopus 로고    scopus 로고
    • Von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma
    • Choueiri TK, Vaziri SA, Jaeger E, et al. von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. J Urol 2008, 180:860-865.
    • (2008) J Urol , vol.180 , pp. 860-865
    • Choueiri, T.K.1    Vaziri, S.A.2    Jaeger, E.3
  • 4
    • 79251635938 scopus 로고    scopus 로고
    • Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
    • Varela I, Tarpey P, Raine K, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011, 469:539-542.
    • (2011) Nature , vol.469 , pp. 539-542
    • Varela, I.1    Tarpey, P.2    Raine, K.3
  • 5
    • 84862988411 scopus 로고    scopus 로고
    • BAP1 loss defines a new class of renal cell carcinoma
    • Peña-Llopis S, Vega-Rubén-de-Celis S, Liao A, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012, 44:751-759.
    • (2012) Nat Genet , vol.44 , pp. 751-759
    • Peña-Llopis, S.1    Vega-Rubén-de-Celis, S.2    Liao, A.3
  • 6
    • 84873081430 scopus 로고    scopus 로고
    • Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
    • published online Jan 16.
    • Kapur P, Peña-Llopis S, Christie A, et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 2013, published online Jan 16. http://dx.doi.org/10.1016/S1470-2045(12)70584-3.
    • (2013) Lancet Oncol
    • Kapur, P.1    Peña-Llopis, S.2    Christie, A.3
  • 7
    • 84863393080 scopus 로고    scopus 로고
    • Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
    • Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892.
    • (2012) N Engl J Med , vol.366 , pp. 883-892
    • Gerlinger, M.1    Rowan, A.J.2    Horswell, S.3
  • 8
    • 84655176646 scopus 로고    scopus 로고
    • Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma
    • Guo G, Gui Y, Gao S, et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet 2011, 44:17-19.
    • (2011) Nat Genet , vol.44 , pp. 17-19
    • Guo, G.1    Gui, Y.2    Gao, S.3
  • 9
    • 84866948962 scopus 로고    scopus 로고
    • Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
    • Sonpavde G, Choueiri TK Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma. Br J Cancer 2012, 107:1009-1016.
    • (2012) Br J Cancer , vol.107 , pp. 1009-1016
    • Sonpavde, G.1    Choueiri, T.K.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.